Respiratory Chain Complexes and OXPHOS-Deficient Models

Capacity, coupling and content are three different deficiencies.

The Three Deficiencies

DeficiencyMeaningReadout
CapacityReduced maximal electron transportMaximal OCR after uncoupler titration
CouplingElectron transport continues but ATP synthesis is weakOligomycin-sensitive fraction; respiratory control ratio
ContentFewer mitochondriamtDNA copy number; complex subunit abundance

Important distinction. A cell can have normal capacity and poor coupling, or reduced content with normal per-mitochondrion function. Because OCR is the product of all three, a fall in OCR alone does not identify which changed. Measuring maximal respiration, the oligomycin-sensitive fraction, and a content marker separates them.

Part 1 — The Complexes

ComplexSubunitsmtDNA-encodedNotable features
I (NADH dehydrogenase)~457Largest; L-shaped; major site of superoxide production at reverse electron transfer
II (succinate dehydrogenase)40Also a TCA enzyme; entirely nuclear-encoded
III (cytochrome bc₁)111Q cycle; superoxide at Qo site
IV (cytochrome c oxidase)133Terminal oxidase; oxygen reduction
V (ATP synthase)~172Rotor; dimer rows shape cristae

Important distinction. Complex II is the only complex with no mtDNA-encoded subunits, which means that ρ0 cells — which lack a mitochondrial genome — retain complex II activity. This is why succinate-linked respiration is preserved in ρ0 cells and is used as a control for mitochondrial content rather than for respiratory competence.

Part 2 — The Models

ModelHow it is madeWhat it modelsCaveat
ρ0 cellsLong-term low-dose ethidium bromide or ddCAbsence of mtDNA-encoded subunitsRequires uridine and pyruvate; extensive adaptation
Complex I knockoutCRISPR of a nuclear subunit (NDUFA9, NDUFS1)Loss of complex ILethal in some lines; compensatory changes
Complex I point mutantsPatient-derived or edited variantsPartial deficiencyHeteroplasmy in mtDNA variants
CybridsTransfer of patient mtDNA into ρ0 backgroundmtDNA variant effectsNuclear background matched; clonal selection
Chemical inhibitionRotenone, piericidin, antimycinAcute loss of a complexOff-target and ROS effects

Caveat on ρ0 cells. They are not simply "cells without OXPHOS". They require uridine (because the pyrimidine synthesis step involving dihydroorotate dehydrogenase is mitochondrial) and often pyruvate (as an NAD⁺ regeneration route), and they adapt over weeks: glycolytic capacity increases, mitochondrial mass may change, and some signalling pathways are altered. A phenotype in ρ0 cells is therefore a phenotype of long-term adaptation to mtDNA loss, not of acute OXPHOS inhibition.

Part 3 — What Each Readout Establishes

ReadoutEstablishesDoes not establish
Basal OCRElectron transport under assay substratesCapacity; coupling
Maximal OCR after titrated uncouplerCapacityWhether capacity is used
Oligomycin-sensitive OCRATP-linked fractionTotal ATP production (other routes contribute)
Respiratory control ratioCoupling qualityCapacity
mtDNA copy numberContentFunction
Complex subunit immunoblotContent of that subunitAssembly or activity
Blue-native gelComplex and supercomplex assemblyActivity
Isolated complex activityEnzyme activityCellular flux

Readout note. Blue-native PAGE is the only routine method that reports assembly, and it is the readout that distinguishes a subunit loss from a loss of holocomplex. Without it, a normal subunit immunoblot in a functionally deficient line is unexplained — and that pattern is common, because assembly defects degrade individual subunits at different rates.

Part 4 — Supercomplexes and Cristae

Respiratory complexes assemble into supercomplexes (I+III₂+IV), and ATP synthase forms dimer rows that shape cristae curvature.

FeatureConsequenceMeasurement
Supercomplex assemblyMay improve electron transfer efficiency and reduce superoxideBlue-native PAGE
ATP synthase dimer rowsCristae curvature; affects proton gradient localisationElectron microscopy; blue-native
Cristae densitySurface area for the ETCElectron microscopy, tomography
OPA1-dependent cristae remodellingRegulates cytochrome c release and respiratory efficiencyOPA1 cleavage forms; imaging

Caveat on inference. Supercomplex abundance correlates with efficiency in some systems and not others, and the causal direction is debated. A change in supercomplexes is a structural observation; a claim that it changed respiratory efficiency requires a functional measurement alongside.

Part 5 — Model Requirements and Recurring Failures

RequirementWhy
Uridine and pyruvate for ρ0Otherwise the cells do not grow
Documented passage after ρ0 generationAdaptation accumulates
Capacity and coupling measured separatelyOCR alone conflates them
Content marker alongside functionSeparates content from specific activity
Complex II-linked respiration as controlPreserved in ρ0; validates the assay
Substrate-specific respirationBasal rate depends on substrate

Recurring failures:

  • • ρ0 cells described as "OXPHOS-deficient" without acknowledging the auxotrophy and adaptation.
  • • Basal OCR reported as capacity.
  • • mtDNA copy number reported as function.
  • • Complex I inhibition used as a model of complex I loss, when rotenone also generates superoxide.
  • • A single complex subunit blot used to conclude assembly status.
  • • ρ0 phenotype attributed to OXPHOS, when uridine or pyruvate availability changed.
  • • No complex II control, so a global assay failure looks like a specific defect.

Part 6 — Where This Article Connects

This is the respiratory-chain article of the mitochondrial cluster: it supplies the models that the OXPHOS-dependency discussion in the pillar refers to, and the readouts that the Seahorse protocol article implements. The membrane potential article covers coupling in more detail; the inhibitor article covers the pharmacological alternatives.

If you need OXPHOS-deficient models with capacity, coupling and content measured separately, we can scope the design with you.

Contact EDITGENE to request a project consultation or quote.

Scientific scope and validation note

Complex abundance, assembly and coupling vary with cell type, passage and culture conditions, and ρ0 adaptation differs between lines. The models here are described at the level of principle.

Reduced oxygen consumption does not establish an ETC defect, and an ETC defect does not establish that ATP supply limits a phenotype.

Scientific interpretation and experimental design

  • • Three deficiencies, three readouts. Capacity, coupling, content.
  • • ρ0 is an adaptation, not an acute knockout. Account for uridine and pyruvate.
  • • Complex II survives mtDNA loss. Use it as the control.
  • • Assembly needs blue-native PAGE.
  • • Inhibitors make superoxide. That is a confound, not a detail.
  • • Copy number is content.

Selected references for further reading

  • • King MP, Attardi G. Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation. Science. 1989;246:500–503.
  • • Letts JA, Sazanov LA. Clarifying the supercomplex: the higher-order organization of the mitochondrial electron transport chain. Nature Structural & Molecular Biology. 2017;24:800–808.
  • • Vercellino I, Sazanov LA. The assembly, regulation and function of the mitochondrial respiratory chain. Nature Reviews Molecular Cell Biology. 2022;23:141–161.

Related Products

Product name Cat.No. Species Gene ID
PBRM1 Knockout A-549 Cell Line EDJ0001-K01 Human 55193 Details Get a Quote
YTHDC1 Knockout A-549 Cell Line EDC07652 Human 91746 Details Get a Quote
TP53 Knockout HCT 116 Cell Line EDC07854 Human 7157 Details Get a Quote
Sirt2 Knockout MH-S Cell Line EDJ-KQ78173 Mouse 64383 Details Get a Quote
TFE3 Knockout KGN Cell Line EDJ-KQ48 Human 7030 Details Get a Quote
Stub1 Knockout MB49 Cell Line EDJ-KQ53 Mouse 56424 Details Get a Quote
ARID1A Knockout SNK-6 Cell Line EDJ-KQ64 Human 8289 Details Get a Quote
Tet1 Knockout Kupffer Cell Line EDJ-KQ88 Mouse 52463 Details Get a Quote
NR1H3 Knockout HEK293T Cell Line EDJ-KQ109 Human 10062 Details Get a Quote
NR1H2 Knockout HEK293T Cell Line EDJ-KQ110 Human 7376 Details Get a Quote
RPS6KB2 Knockout HEK293 Cell Line EDJ-KQ125 Human 6199 Details Get a Quote
SMAD6 Knockout HEK293 Cell Line EDJ-KQ126 Human 4091 Details Get a Quote
JUN Knockout HEK293 Cell Line EDJ-KQ176 Human 3725 Details Get a Quote
JUN Knockout HEK293T Cell Line EDJ-KQ184 Human 3725 Details Get a Quote
ALKBH5 Knockout HEK293 Cell Line EDJ-KQ186 Human 54890 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: